Covid-19 Sample Collection Kits Market Analysis & Forecast: 2026-2033

Covid-19 Sample Collection Kits Market Size and Forecast – 2026 to 2033

The Covid-19 Sample Collection Kits Market is estimated to be valued at USD 6.4 Bn in 2026 and is expected to reach USD 12.3 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.3% from 2026 to 2033.

Key Takeaways

• By Product Type, Swabs hold the largest market share of 42.2% in 2026 owing to its rising demand for infectious disease diagnostics.
• By Application, Diagnostic expected to hold largest market share of 52.4% in 2026 owing to the rising demand for accurate COVID-19 detection.
• By End User, COVID-19 Testing Centers acquired the prominent market share of 38.4% in 2026 owing to its surge in COVID-19 testing demand.
• By Region, North America dominates the overall market with an estimated share of 38.8% in 2026 owing to the strong presence of diagnostic and biotechnology companies.

Market Overview

The global need for accurate and large-scale testing drove the rapid expansion of the COVID-19 Sample Collection Kits Market during the pandemic. These kits typically include swabs, viral transport media, and collection tubes, which healthcare professionals use to collect respiratory samples for diagnostic procedures. Hospitals, diagnostic laboratories, and dedicated testing centers increased their demand for these kits. Governments and healthcare organizations also invested heavily in testing infrastructure, further driving market growth. Ongoing efforts in infectious disease surveillance and preparedness for future outbreaks continue to sustain the demand for reliable sample collection solutions.

Current Events and their Impact on the Covid-19 Sample Collection Kits Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights 

To learn more about this report, Download Free Sample

Covid-19 Sample Collection Kits Market Insights, By Application: Diagnostic contribute the highest share of the market owing to its advancements in diagnostic technologies.

Diagnostic expected to hold largest market share of 52.4% in 2026. The increasing need for timely and accurate disease detection drives the growth of the diagnostic segment in the COVID-19 Sample Collection Kits Market. Diagnostic laboratories and healthcare facilities use properly collected specimens to conduct molecular and antigen tests. The expansion of testing capabilities and improvements in laboratory infrastructure have increased the demand for reliable sample collection kits. Healthcare systems also conduct continuous surveillance of infectious diseases and adopt advanced diagnostic technologies, which encourages the consistent use of standardized sample collection systems in clinical and public health environments. For instance, Minister of State for Education Shri Sanjay Dhotre launched a COVID-19 Rapid Antigen Test kit developed by IIT Delhi researchers led by Dr. Harpal Singh of the Centre for Biomedical Engineering.

Covid-19 Sample Collection Kits Market Insights, By Product Type: Swabs contribute the highest share of the market owing to its growth of home-based and self-collection testing.

Swabs hold the largest market share of 42.2% in 2026. The need for reliable specimen collection for diagnostic testing significantly increased the demand for swabs in the COVID-19 Sample Collection Kits Market. Healthcare professionals used nasopharyngeal and oropharyngeal swabs to collect accurate respiratory samples for laboratory analysis. The expansion of testing centers, hospitals, and diagnostic laboratories further increased the use of these products. Manufacturers also improved swab materials and designs to enhance sample absorption and release efficiency. Ongoing monitoring of respiratory infections and preparation for future outbreaks continue to support the demand for medical swabs. For instance, Amazon launched an at-home COVID-19 test kit, letting customers quickly and easily collect samples using gentle lower nasal swabs, with free Amazon Prime delivery.

Covid-19 Sample Collection Kits Market Insights, By End User: COVID-19 Testing Centers contribute the highest share of the market owing to its rapid screening for travel and workplace safety.

COVID-19 Testing Centers acquired the prominent market share of 38.4% in 2026. COVID-19 testing centers have strongly driven the sample collection kits market by serving as primary locations for large-scale specimen collection. Hospitals, drive-through sites, and community testing facilities use swabs, transport media, and collection tubes to handle high testing volumes efficiently. Government initiatives and public health programs have expanded these centers, while mobile and temporary facilities have increased testing accessibility. Rising public awareness and the demand for rapid, reliable testing continue to sustain the use of sample collection kits at these centers. For instance, Genomics company Mapmygenome opened a drive-through COVID-19 testing facility yesterday at Cyient Foundation MP Primary and ZP High School in Gachibowli, Hyderabad, allowing individuals and families to park and get tested on-site.

Regional Insights 

To learn more about this report, Download Free Sample

North America Covid-19 Sample Collection Kits Market Trends

North America dominates the overall market with an estimated share of 38.80% in 2026. Widespread testing and strong healthcare infrastructure have driven notable growth in North America’s COVID-19 Sample Collection Kits Market. Hospitals, diagnostic laboratories, and dedicated testing centers actively use swabs, viral transport media, and collection tubes to obtain accurate specimens. Innovations in kit design and the growing adoption of home-testing solutions continue to shape market trends. Governments and public health programs have promoted large-scale testing, while ongoing efforts to prepare for infectious disease outbreaks sustain demand and encourage continuous advancements in sample collection technologies. For instance, Biogen Inc., Broad Institute of MIT and Harvard, and Partners HealthCare formed a consortium to create a COVID-19 biobank, enabling scientists to study de-identified biological and medical data to advance vaccines and treatments.

Asia Pacific Covid-19 Sample Collection Kits Market Trends

Rising testing demand and strengthening healthcare infrastructure have driven rapid growth in the Asia Pacific COVID-19 Sample Collection Kits Market. Countries actively expanded hospitals, diagnostic laboratories, and community testing centers to enhance early infection detection. Healthcare providers and consumers increasingly use innovative swab designs and user-friendly kits for both clinical and home-based testing, shaping market dynamics. Governments implement mass testing campaigns, public awareness programs, and invest in laboratory capacity, while ongoing preparedness for future outbreaks sustains demand and promotes continuous development of reliable sample collection solutions. For instance, Dr. VK Saraswat, NITI Aayog member and President of SCTIMST, announced the commercial launch of Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit for COVID-19 testing, in a program attended virtually by Prof. Ashutosh Sharma, Dr. Asha Kishore, Dr. HK Varma, and SCTIMST scientists.

United States Covid-19 Sample Collection Kits Market Trends

Extensive testing programs and a well-established healthcare infrastructure have driven significant growth in the United States COVID-19 Sample Collection Kits Market. Hospitals, diagnostic laboratories, and testing centers actively use swabs, viral transport media, and collection tubes to collect accurate specimens. Innovations in kit design and the expansion of at-home testing solutions continue to shape market developments. Federal and state government initiatives, together with public health campaigns, promote widespread testing, while ongoing monitoring of infectious diseases encourages healthcare providers to adopt advanced, reliable sample collection kits in both clinical and community settings. For instance, Quest Diagnostics launched an at-home COVID-19 rapid antigen test for purchase through its consumer platform, QuestDirect.

China Covid-19 Sample Collection Kits Market Trends

Large-scale testing initiatives and strong government support for public health have driven rapid growth in China’s COVID-19 Sample Collection Kits Market. Hospitals, diagnostic laboratories, and community testing centers actively collect accurate specimens using swabs, viral transport media, and collection tubes. Healthcare providers increasingly adopt innovative collection kits and streamlined testing processes to improve efficiency. Government-led mass testing campaigns, investments in laboratory infrastructure, and rising public awareness continue to boost demand, while ongoing preparedness for infectious disease outbreaks encourages the development and widespread use of reliable sample collection solutions.

Covid-19 Sample Collection Kits Market Trend

Shift Toward Home-Based and Self-Collection Kits

The market is moving toward home-testing solutions, allowing individuals to collect samples safely and conveniently. Self-collection kits include swabs, transport tubes, and clear instructions to ensure accurate specimen collection without professional supervision. This trend reduces hospital congestion, supports telehealth initiatives, and enhances accessibility in remote or high-risk areas. Manufacturers are innovating user-friendly designs to increase adoption, making home testing a sustainable part of ongoing COVID-19 and infectious disease management.

Innovation in Swab and Collection Materials

Advancements in swab design, such as flocked tips and flexible shafts, improve sample absorption and patient comfort. Viral transport media and preservative solutions are also being enhanced for longer stability and safer handling. These innovations increase the reliability of diagnostic results, reduce sample degradation, and support broader adoption in hospitals, laboratories, and testing centers. Continuous research and material improvements remain a key trend to meet evolving testing requirements.

Covid-19 Sample Collection Kits Market Opportunity

Growth in Home-Based and Self-Collection Testing

Rising consumer preference for convenient and safe testing creates opportunities for self-collection kits. Companies can design user-friendly kits with clear instructions, pre-labeled tubes, and secure packaging for accurate home specimen collection. Expanding telehealth services and remote diagnostics further drive this opportunity. By offering kits compatible with both PCR and rapid antigen tests, manufacturers can tap into growing demand for accessible testing solutions beyond clinical settings, improving reach in urban and remote communities.

Market Report Scope 

Covid-19 Sample Collection Kits Market News

• In November 2021, Genes2Me launched the RT-Direct Multiplex RTPCR kit for COVID-19, targeting three SARS-CoV-2 genes plus IC, offering more advanced detection than kits with one or two genes.

Analyst Opinion (Expert Opinion)

• The COVID‑19 Sample Collection Kits landscape has matured beyond the explosive demand seen in early pandemic years, revealing structural market dynamics that are far from homogeneous. Data across multiple industry analyses highlight a bifurcation: while aggregate demand remains significant, the volume and revenue trajectories for core products such as swabs and viral transport media are increasingly shaped by nuanced clinical and public health imperatives rather than pure volume growth. A decline in traditional swab‑based procurement in key markets such as the U.S.—where revenue is projected to contract meaningfully through the end of the decade—indicates that legacy reliance on nasopharyngeal sampling is giving way to diversified specimen modalities and evolving testing protocols.
• Critically, adoption patterns underline a substantive shift toward specialized and decentralized formats. For example, regulatory ecosystems in North America and Europe have authorized hundreds of test and collection device combinations, including self‑collection kits that have demonstrated strong user compliance in large cohorts (e.g., tens of thousands of unobserved self‑collected swab specimens yielding adequate samples in community settings). This trend underscores a departure from centralized clinical procurement towards hybrid models that integrate self‑sampling with central lab analytics—reshaping demand curves for collection kits and associated consumables.
• From a competitive vantage, the landscape is shaped by strategic realignment rather than sheer scale. Legacy diagnostics firms have shifted emphasis to modular, platform‑agnostic collection solutions that complement broader testing ecosystems (e.g., integrated PCR workflows and multiplexed respiratory panels). This repositioning suggests a recognition that sustainable value in this market will accrue to players who can integrate specimen collection into holistic diagnostic pathways rather than those who compete purely on kit volumes.

Market Segmentation

• By Product Type
  • Swabs
  • Nasal swab
  • Nasopharyngeal swab
  • Oropharyngeal swab
  • Viral Transport Media
  • Others
• By Application
  • Diagnostic
  • Research
• By End User
  • Hospital and Clinics
  • COVID-19 Testing Centers
  • Others
• By Regional Insights
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • MyLab Discovery Solutions
  • Bhat Bio-Tech
  • Camtech Diagnostics
  • Angstrom Biotech Pvt. Ltd.
  • Medsource Ozone Biomedicals Pvt Ltd.
  • Neuromics
  • Oscar Medicare Pvt. Ltd.
  • GenBody Inc.
  • Alimetrix, Binx Health
  • Clinical Enterprise
  • Bio-Rad Laboratories
  • Ethos Laboratories
  • GetMyDNA
  • Kroger
  • LabCorp
  • RapidRona
  • EKF Diagnostics
  • Everlywell, Inc.
  • Copan Diagnostics.

Sources

Primary Research interviews

• Healthcare professionals (doctors, nurses, lab technicians)
• Hospital procurement managers
• Clinical laboratory managers
• Diagnostic center executives
• Public health officials
• Epidemiologists involved in COVID-19 testing

Databases

• World Health Organization (WHO) COVID-19 databases
• Centers for Disease Control and Prevention (CDC) data portals
• National health ministry data portals (country-specific)
• PubMed database for research articles
• Global Health Observatory (GHO) data

Magazines

• The Lancet Infectious Diseases magazine
• Nature News & Views
• Scientific American
• New Scientist
• Journal of Medical Virology (magazine editions)

Journals

• Journal of Clinical Microbiology
• International Journal of Infectious Diseases
• Emerging Infectious Diseases
• Virology Journal
• Clinical Microbiology and Infection

Newspapers

• The New York Times (Health section)
• The Guardian (Health & Science section)
• The Washington Post (Science & Health section)
• Hindustan Times (Health section)
• Reuters Health News

Associations

• American Society for Microbiology (ASM)
• International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
• Infectious Diseases Society of America (IDSA)
• European Centre for Disease Prevention and Control (ECDC)
• Association of Public Health Laboratories (APHL)

Public Domain sources

• Government COVID-19 portals and reports
• WHO COVID-19 situation reports
• CDC COVID-19 guidance and reports
• National Institute of Health (NIH) COVID-19 publications
• Open-access COVID-19 research repositories

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years